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Objective: Protein malnutrition (PM) often is associated with changes in bone marrow (BM)
microenvironment leading to an impaired hematopoiesis; however, the mechanism involved is
poorly understood. The aim of this study was to compare the cell cycle progression of hemato-
poietic stem cells (HSC) and hematopoietic progenitor cells (HPC) and evaluate the cell cycle
signaling in malnourished mice to assess the mechanism of cell cycle arrest.
Methods: C57Bl/6J mice were randomly assigned in control and malnourished groups receiving
normoproteic and hypoproteic diets (12% and 2% protein, respectively) over a 5-wk period.
Nutritional and hematologic parameters were assessed and BM immunophenotypic analysis was
performed. Cell cycle of HPC (Lin–) and HSC (Lin–Sca-1þc-Kitþ) were evaluated after 6 h of in vivo
5-bromo-2’-deoxyuridine (BrDU) incorporation. Cell cycle regulatory protein expression of HPC
was assessed by Western blot.
Results: Malnourished mice showed lower levels of serum protein, albumin, glucose, insulin-like
growth factor-1, insulin, and higher levels of serum corticosterone. PM also caused a reduction
of BM myeloid compartment resulting in anemia and leukopenia. After 6 h of BrDU incorporation,
malnourished mice showed G0-G1 arrest of HPC without changes of HSC proliferation kinetics.
HPC of malnourished mice showed reduced expression of proteins that induce cell cycle (cyclin D1,
cyclin E, pRb, PCNA, Cdc25a, Cdk2, and Cdk4) and increased expression of inhibitory proteins (p21
and p27) with no signiﬁcant difference in p53 expression.
Conclusion: PM suppressed cell cycle progression mainly of HPC. This occurred via cyclin D1 down-
regulation and p21/p27 overexpression attesting that BM microenvironment commitment
observed in PM is affecting cell interactions compromising cell proliferation.
 2014 Elsevier Inc. All rights reserved.Introduction circumstances, the 2010 Food and Agriculture Organization reportAs a deﬁnition, malnutrition may be taken as a subacute or
chronic state of nutrition in which a combination of varying de-
grees of malnutrition and inﬂammatory activity lead to changes in
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ll rights reserved.[2] estimated that globally 925million peopleweremalnourished,
mostly in developing countries. However, several conditions apart
from social establishments may lead to malnutrition. These
include eating disorders, individuals with chronic disease, and
long-term hospitalization [3–5], contributing to a worldwide
public health problem. Clinically, the consequences of malnutri-
tion have been associated with metabolic alterations, increased
susceptibility to infections [6,7], and histologic and functional
changes in several tissues, including bone marrow (BM) [8,9]. In
fact, anemia and leukopenia reﬂect the hematopoietic tissue
commitment in response to malnutrition and are associated with
modiﬁcation of the immune system that translates into increased
susceptibility to infection [10–13], which is especially relevant to
hospitalized individuals.
Table 2
Nutritional and hormonal parameters
Parameters Control
(n ¼ 8)
Malnourished
(n ¼ 10)
P-value
Body weight variation (%) þ27.2  2.8 5.6  0.8z <0.0001
Food consumption (g/d/animal) 3.6  0.1 4.5  0.1z <0.0001
Protein consumption (g/d/animal) 0.44  0.01 0.12  0.04z <0.0001
Calorie intake (kcal/d) 13.95  0.37 16.92  0.48z <0.0001
Total serum protein (g/dL) 5.1  0.4 4.2  0.3* 0.0451
Serum albumin (g/dL) 2.0  0.1 1.7  0.1* 0.0268
Serum glucose (mg/dL) 101.8  7.4 69.4  4.0y 0.0014
Insulin concentration (ng/mL) 0.62  0.09 0.24  0.05y 0.0041
IGF-1 concentration (ng/mL) 546  107 255  420y 0.0066
Corticosterone concentration
(ng/mL)
12.3  0.1 40.2  7.1* 0.0174
IGF, insulin-like growth factor
Data set analyzed by the Student’s t test. Values are expressed as mean  SD
(*P < 0.05; y P < 0.01; z P < 0.001)
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extremely inﬂuenced by the availability of nutrients, because
they are essential for cell cycle progression directly or indirectly
[14]. Several studies highlight abnormalities in myelopoiesis
and lymphopoiesis, followed by peripheral pancytopenia as a
consequence of protein malnutrition (PM) [13,15–18]. We have
demonstrated BM hypoplasia and structural breakdown with
changes in the extracellular matrix (ECM) and stromal cells [8,9].
Cell cycle arrest of hematopoietic cells also has been observed
with a delayed BM reconstitution after 5-ﬂuoruracil treatment in
malnourished mice [13,19].
There are two restricted populations of hematopoietic stem
cells (HSC) and hematopoietic progenitor cells (HPC) in BM that
have the ability to generate all blood cell lineages in appropriate
amounts to maintain system homeostasis. This is achieved due
to strict cell cycle control mediated by extrinsic factors within
BM and intrinsic factors at the cell level [20]. Therefore, cell in-
teractions activate cell cycle signaling, promoting an orches-
trated transition between G1-S-G2-M phases, which is regulated
by cyclins and its effectors, cyclin-dependent kinase (Cdk) and
cyclin-dependent kinase inhibitor (CKI) [21–24]. Thus, extracel-
lular stimuli induces cyclin D1 expression and consequent cyclin
D1/cdk4,6 complex formation responsible for the initial phos-
phorylation of retinoblastoma transcriptional repressors (pRb,
p107, and p130), which keeps the E2F gene repressed. This initial
phosphorylation promotes cyclin E synthesis and cyclin E/cdk2
complex formation, which further inactivates pRb-mediated in-
hibition of E2F, resulting in the G1-S transition. Meanwhile,
members of the CKI family, namely inhibitors of kinase 4 (INK4:
p15, p16, p19) and CDK interacting protein/kinase inhibitory
protein (CIP/KIP: p21, p27) inhibit activation of the cyclin-cdk
complexes, promoting a ﬁner control of cell cycle progression
[25–29].
Whereas the BM microenvironment commitment resulting
from PM could compromise cell interactions, it is assumed that
such a condition may blunt cyclin D1 expression, which in turn
jeopardizes cell cycle initiation. To better understand the
mechanisms involved in hematopoiesis impairment due to PM,
we evaluated the effects of PM on HPC cell cycle signaling.Materials and methods
Animals and diets
Two-mo-old male C57Bl/6J mice were obtained from the Animal Labora-
tory of Faculty of Pharmaceutical Sciences at the University of S~ao Paulo. The
mice (N ¼ 26) were housed individually in metabolic cages (temperature
controlled at 22  2C and a relative humidity of 55  10% under a 12-h light/
12-h dark cycle). After 2 wk of adaptation, the mice were randomly assigned to
control (C) and malnourished (M) groups receiving normoproteic (12% protein)
and a hypoproteic (2% protein) diets, respectively, over 5-wk periods. TheTable 1
Nutrient composition of the two experimental diets (g/1000 g of diet)
Ingredients Normoproteic diet Hypoproteic diet
Casein 120 20
Sucrose 100 100
Soybean oil 40 40
Fiber 50 50
Choline bitartrate 2.5 2.5
L-cystine 1.8 0.3
Tert-butylhydroquinone 0.008 0.008
Vitamin mixture 10 10
Mineral mixture 35 35
Cornstarch 640.692 742.192murine diets (Table 1) were prepared in our laboratory according to the rec-
ommendations of the American Institute of Nutrition [30]. Mice were given
free access to food and water. At the end of week 5, all mice were sacriﬁced
under anesthesia with 10 mg/kg of xylazin (Rompum, Bayer, SP, Brazil) and 100
mg/kg of ketamine (Ketamina, Cristalia, SP, Brazil) between 0700 and 0900.
The mice were fasted for 8 h before sacriﬁce. This study was approved by the
Ethics Committee on Animal Experimentation of the Faculty of Pharmaceutical
Sciences (CEEA n 92), University of S~ao Paulo, and was conducted according to
the guidelines of the Brazilian College on Animal Experimentation.Nutritional and hormonal evaluation
The nutritional status was assessed by body mass variation, diet consump-
tion, and serum protein, albumin, and glucose determination using commercial
kits (Labtest, MG, Brazil). The hormonal proﬁle was evaluated by enzyme-linked
immunosorbent assay (ELISA) quantiﬁcation of serum insulin (Rat/Mouse Insulin
ELISA, LINCO, St. Charles, MO, USA), insulin-like growth factor (IGF-1, Mouse IGF-
1 Quantikine ELISA, R&D System, Minneapolis, MN, USA) and corticosterone
(corticosterone EIA, IDS, Boldon, UK). The colorimetric analyses were assessed in
a plate reader (EL800 Universal Microplate Reader - Instrumentals Bio-Tek Inc,
Winooski, VT, USA).Hematologic evaluation
Blood samples with EDTA (Sigma-Aldrich, St Louis, MO, USA) as anticoagu-
lant were used for hemogram evaluation performed on ABX Micros ABC Vet
equipment (Horiba, Montpellier, France). Morphologic and leukocyte differenti-
ation analyses were carried out on blood smears stained with standard May-
Grunwald Giemsa technique. For reticulocyte identiﬁcation, a supravital dye
was used and quantiﬁcation was performed on smear preparations. Total BM
cells were harvested from both femur and tibia cavities using Iscove’s medium
(Sigma-Aldrich, St. Louis, MO, USA) and used for myelogram and immunophe-
notyping analyses. For myelogram, total cell counts were carried out using a
Newbauer Chamber followed by differential counts using cytocentrifuge prepa-
rations stained with May-Grunwald Giemsa in which 300 cells per slide per
animal were counted.Table 3
Bone marrow cell counts
Control
(n ¼ 6)
Malnourished
(n ¼ 6)
P-value
Total cells (103/mm3) 40.7  1.4 30.3  1.5z <0.0001
Blast cells (103/mm3) 1.0  0.2 0.5  0.1* 0.0445
Granulocyte precursors (103/mm3) 2.7  0.3 1.7  0.1* 0.0304
Band/segmented cells (103/mm3) 17.8  0.6 13.6  0.9* 0.0192
Eosinophil (103/mm3) 0.5  0.1 0.2  0.1* 0.0149
Lymphocyte (103/mm3) 8.4  1.2 7.5  0.7 0.5982
Macrophage (103/mm3) 0.1  0.0 0.1  0.0 0.5200
Total erythroblast (103/mm3) 9.3  0.5 5.8  0.3y 0.0052
Data set analyzed by the Student’s t test. Values expressed as mean  SD
(*P < 0.05; y P < 0.01; z P < 0.001)
Fig. 1. Total bone marrow immunophenotypic analysis. Representative ﬂow cytometer analysis of BM cell populations of control (n ¼ 4) and malnourished (n ¼ 4) animals:
progenitors cells (CD45þCD34þ); granulomonocyte cells (Gr-1þCD11bþ); total erythroid cells (Ter119þ); erythroid precursors (Ter119þCD71þ); total B lymphocytes
(CD19þCD5–); total T lymphocytes (CD3þ); lymphocyte T CD4þ (CD3þCD4þ); and lymphocyte T CD8þ (CD3þCD8þ).
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Flow cytometer was used to perform immunophenotypic analysis of total BM
cells. Before antibody labeling, red cells were lysed using ammonium chloride
buffer (NH4Cl 150 mM, NaHCO3 10 mM, EDTA 0,1 mM, pH 7,4) and washed twice
with PBS solution (PBS buffer containing 2 mM EDTA, 0,5% BSA, 0,01% sodium
azide, pH 7,4). Then, 1  106 total BM cells were incubated with following anti-
bodies: CD34-FITC, CD45-APC, CD11b-FITC, Gr-1-APC, Ter119-FITC, CD71-PE,
CD5-APC, CD19-PE, CD3-FITC, CD4-APC, and CD8-PE (BD Pharmingen, Franklin
Lakes, NJ, USA). For all antibodies, a correspondent negative control was assessed.
50000 cells were acquired on FACSCanto II ﬂow cytometer (Becton Dickson,Franklin Lakes, NJ, USA) using 488 nm and 633 nm excitation lasers. Data were
analyzed with FlowJo 7.6 software (TreeStar, Ashland, OR, USA).
Cell cycle assessment
Cell cycle evaluation was performed using APC 5-bromo-2’-deoxyuridine
(BrDU) Flow kit (BD Pharmingen, Franklin Lakes, NJ, USA) following the manu-
facturer’s instructions. Brieﬂy, both C and M group animals were treated intra-
peritoneally with a BrDU solution (1 mg per animal) 6 h before sacriﬁce. The HPC
(immunophenotypically characterized as Lin– because those cells do not expresses
any lineage markers) were obtained by negative depletion from BM using the
Table 4
Immunophenotypical analysis of bone marrow cells
Control
(n ¼ 4)
Malnourished
(n ¼ 4)
P-value
HSC (Lin–Sca1þc-Kitþ) 0.06  0.01% 0.03  0.01%* 0.0246
HPC (Lin–) 3.6  0.4% 2.5  0.2%y 0.0088
Progenitors cells (CD45þCD34þ) 18.7  1.4% 10.9  1.9%* 0.0168
Total erythroid cells (Ter119þ) 31.2  4.5% 11.1  5.5%* 0.0465
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Cologne, Germany) according to the manufacturer’s instructions. Lin– cells were
then labeled with Sca-1-FITC (eBiosciences, San Diego, CA, USA) and c-Kit-PE
(BD Pharmingen, Franklin Lakes, NJ, USA) for HSC (immunophenotypically char-
acterized as Lin–Sca-1þcKitþ) quantiﬁcation. Cell cycle evaluation was conducted
on both HPC and HSC. 50000 cells were acquired on FACSCanto II ﬂowcytometer
(Becton Dickson, Franklin Lakes, NJ, USA) using 488 nm and 633 nm excitation
lasers and data were analyzed with FlowJo 7.6 software (TreeStar, Ashland,
OR, USA).Erythroid precursors (Ter119þ
CD71þ)
18.6  2.8% 5.6  2.9%* 0.0330
Granulomonocyte cells (CD11bþ
Gr-1þ)
44.6  4.7% 28.1  3.9%* 0.0362
B lymphocyte (CD19þCD5–) 11.2  0.9% 7.9  2.5% 0.2218
T lymphocyte (CD3þ) 7.9  2.6% 10.3  2.4% 0.5246
Lymphocyte T CD4 (CD3þCD4þ) 0.9  0.1% 1.2  0.2% 0.3202
Lymphocyte T CD8 (CD3þCD8þ) 1.6  0.4% 2.8  0.6% 0.1628
HPC, hematopoietic progenitor cells; HSC, hematopoietic stem cells
Data set analyzed by the Student’s t test. Values are expressed as mean  SD
(*P < 0.05, y P < 0.01)Western blot analysis
1  106 HPC were lysed for the extraction of total proteins using RIPA
buffer (Pierce, Rockford, IL, USA) containing protease and phosphatase in-
hibitors (0.5 mM PMSF, 50 mM NaF, 10 ug/mL leupeptin, and 10 ug/mL apro-
tinin, Sigma Aldrich, St. Louis, MO, USA). After total protein quantiﬁcation using
a commercial kit (BCATM protein assay kit, Pierce, Rockford, IL, USA) sodium
dodecyl sulfate polyacrylamide gel electrophoresis (8%–10%) was performed
using 50 ug of protein followed by a polyvinylidene ﬂuoride membrane (PVDF,
Amersham Biosciences, Pittsburg, PA, USA) transfer. After overnight incubation
with primary antibodies (cyclin D1, cyclin E, phosphorylated pRb, Cdk-2, Cdk-4,
Cdc-25a, PCNA, p21, p27, and p53; all from BD Pharmingen, Franklin Lakes, NJ,
USA) at a 1:1000 dilution, membranes were washed with TBS-Tween buffer and
incubated with horseradish peroxidase-labeled secondary antibody (dilution
1:2000) for 1 hour. Following three washes, immunoreactive bands were
visualized using the ECL detection system (Amersham Biosciences, Pittsburg,
PA, USA) and images captured using ImageQuantTM 400 version 1.0.0
(Amersham Biosciences, Pittsburg, PA, USA). For standardization and quantiﬁ-
cation, the images were analyzed using ImageQuant TL program (Amersham
Biosciences, Pittsburg, PA, USA). Results were expressed in relation to the in-
tensity of b-actin (Sigma-Aldrich, St. Louis, MO, USA).Statistical analysis
After a normality test, all data sets were analyzed by the Student’s t test and
the level of signiﬁcance adopted was P < 0.05. All data were expressed as
mean  SD. Statistical analyzes were performed using the GraphPad Prism
software version 5.01 (GraphPadSoftware Inc., CA, USA).Results
PM alters hormonal and nutritional status
Mice fed a low-protein diet displayed higher food intake
than their control counterparts. Nevertheless, the low-
protein intake was reﬂected in the loss of body mass and
signiﬁcant reduction in serum protein, albumin, and glucose
levels (Table 2). Malnourished mice showed lower serum in-
sulin and IGF-1 levels, which are hormones associated with
protein anabolism, and higher serum corticosterone levels
(Table 2), a catabolic hormone that could also contribute to the
higher susceptibility to infections was observed in this con-
dition [31].Table 5
Peripheral blood parameters
Control
(n ¼ 10)
Malnourished
(n ¼ 10)
P-value
Total erythrocyte (106/mm3) 9.3  0.4 7.8  0.3y 0.0082
Hemoglobin (g/dL) 13.3  0.4 12.0  0.3y 0.0094
Hematocrit (%) 38.6  0.9 33.6  1.2y 0.0030
Reticulocytes (%) 4.0  0.2 3.2  0.2y 0.0045
Total leukocyte (/mm3) 2532  251 1338  211y 0.0012
Neutrophil (/mm3) 296.2  49.8 158.5  114.4* 0.0360
Lymphocyte (/mm3) 2448.0  306.5 1407.1  341.6* 0.0381
Eosinophil (/mm3) 3.1  9.2 0,.0  0.0 0.0593
Monocyte (/mm3) 81.9  21.4 30.2  10.1* 0.0402
Data set analyzed by the Student’s t test. Values are expressed as mean  SD
(*P < 0.05; yP < 0.01)Hematologic impairment in response to PM
Malnourished mice showed BM hypoplasia with a striking
reduction of granulocytic and erythroid cells, with no difference
of lymphoid population as observed on both morphologic
(Table 3) and immunophenotypical analysis (Fig. 1; Table 4).
Malnourished mice showed a signiﬁcantly lower percentage of
HPC (Lin–) and HSC (Lin–Sca-1þc-Kitþ) in BM compared with
control mice (Table 4), suggesting a decline in self-renewal and
proliferation processes. Such changes in BM compartment
resulted in leukopenia and anemia with signiﬁcant reduction in
the number of reticulocytes, indicating a non-regenerative ane-
mia (Table 5).PM inhibited cell cycle progression
After 6 h of BrDU incorporation there was no signiﬁcant dif-
ference of HSC proliferation kinetics between control (G0-G1
75.9  0.7%; S 22.7  0.6%; G2-M 1.4  0.1%) and malnourished
animals (G0-G1 74.0  0.9%; S 24.6  0.9%; G2-M 1.4  0.2%)
(Fig. 2A). However, after 6 h, the HPC of malnourished animals
had entered into a cell cycle with lower frequency because they
presented a higher percentage of HPC in G0-G1 (C 71.7  2.1%; M
80.1  2.2%), with a diminished percentage of cells in S (C 24.8 
2.3%; M 15.80  1.5%) and G2-M phases (C 4.7  0.3%; M 2.5 
0.3%) (Fig. 2B). We also observed that malnourished mice dis-
played an inversed pattern of proliferation rate in which HPC
became more quiescent then HSC (Fig. 3).
Cell cycle signaling modulation in PM
By investigating the inﬂuence of PM on the intrinsic cell cycle
control we ascertained that HPC of malnourished animals had a
signiﬁcantly lower expression of cyclin D1, cyclin E, Cdk2, cdc25a,
and a non-signiﬁcant difference of Cdk4 expression (Fig. 4). As a
consequence, phosphorylated pRb and PCNA expression also were
signiﬁcantly reduced, indicating a non-progression of cell cycle. In
contrast, HPC of malnourished animals exhibited a signiﬁcantly
higher expression of p21 and p27 comparedwith cells from control
animals (Fig. 4). There was no difference of HPC p53 expression.
Discussion
Although malnourished mice presented a higher energy
intake, the insufﬁcient amount of protein compromised their
Fig. 2. Effects of PM on cell cycle analysis 6 h after BrDU incorporation. (A) ﬂow cytometry analysis of HSC (Lin–Sca-1þcKitþ) BrDU incorporation and cell percentage in G0-G1
and S phases. (B) ﬂow cytometry analysis of HPC (Lin–) BrDU incorporation and cell percentage in G0-G1, S, and G2-M phases. Mean  SD of control (n ¼ 5) and malnourished
(n ¼ 5) groups with signiﬁcant difference when *P < 0.05 and yP < 0.01. Data set analyzed by the Student’s t test.
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Fig. 3. Proliferation kinetics comparison between HSC and HPC. Cell percentage comparison of HSC and HPC in G0-G1, S and G2-M phases of control and malnourished
groups. Mean  SD with signiﬁcant difference when *P < 0.05, yP < 0.01, and zP < 0.001. Data set analyzed by the Student’s t test.
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and hematologic alterations consistent with the literature [8–13,
15–18,32,33]. Concerning the hormonal status, themalnourished
group showed lower serum insulin and IGF-1 levels than the
control group. IGF-1 is directly related to the protein metabolism
and anabolism [34] and it has been proposed that the amount of
energy and protein in the diet are primary determinants of
serum IGF-1 levels during growth [35]. Thus, the decrease of
serum IGF-1 and insulin levels are related to the reduction of
anabolic action favoring protein catabolism. Additionally, dietary
protein deﬁciencymay provoke an increase in protein catabolism
by the action of glucocorticoids, whose plasma concentration is
increased [36].
Regarding hematologic data, malnourished mice presented
peripheral cytopenia due to BM hypoplasia, which is in accor-
dance with previous studies [8,15–18]. As already discussed in
other studies, those alterations could, in part, contribute to the
increased susceptibility to infections observed in this condition
[6,7,10–13], making it a major public health problem worldwide.
In previous data [13–18], our group demonstrated a reduction of
hematopoietic progenitors in BM and spleen, especially of the
erythroid precursors in response to PM. Herein, by screening all
BM cell lineages, we conﬁrmed a myeloid shrinkage with a slight
reduction of the lymphoid compartment. In the present study,
we also demonstrated that PM directly affects the amounts of
HPC and HSC within BM, both considered more primitive pop-
ulations. These ﬁndings are highly relevant if we consider that
HSC and HPC are the key points that regulate the hematopoiesis:
from their self-renewal, differentiation, and proliferation pro-
cesses, blood system homeostasis is maintained under physio-
logical conditions.
It has been suggested that quantitative changes may arise
from two distinct events within BM: increased apoptotic pro-
cesses and/or reduction of cell proliferation. Both processes
depend on the BMmicroenvironment integrity and are therefore
susceptible to the effects of malnutrition. Previous observation
[18] excludes an increase in the apoptotic events, suggesting that
compensatory mechanisms such as autophagy [37,38] may pre-
vent programmed cell death in an attempt to bring organismhomeostasis in response to nutrient deprivation. Other studies,
however, show the nutritional status inﬂuence on hematopoiesis
suggesting that malnutrition compromises the process of pro-
liferation and maintenance of hematopoietic tissue [15–18]. One
study [19] demonstrated the retention of BM cells in G0-G1 of
malnourished animals and, after myeloablative treatment with
5-ﬂuorouracil, reconstitution of the hematopoietic tissue was
delayed, indicating that PM impairs cell cycle progression. In this
study, we observed that the PM also caused G0-G1 arrest of HPC
without affecting the proliferation kinetics of HSC after 6 h of
BrDU incorporation. Considering that we assessed a short period
of time, we are unable to predict whether PM causes cell cycle
arrest of HSC for those cells predominate in a rest transient state
in order to maintain their self-renewal and differentiation ability
[39,40]. Regarding the diminished HSC pool of malnourished
mice, it is assumed that those cells proliferate at some point, and
the differentiation process supposedly overcame the self-renewal
process. Nevertheless, those data indicated that malnourished
mice were unable to maintain tissue homeostasis, since even
with reduced BM and peripheral cellularity HPC and HSC did not
shorten their turnover time to thereby restore tissue integrity. On
the contrary, HPC became more quiescent due to PM, perhaps in
an attempt to protect from irreversible DNA damage. Thus, cells
with a high proliferative rate might be more susceptible to the
effects of PM leading to the BM hypoplasia.
Together with the observation of a restrained G0-G1-S
transition of HPC due to PM, cell cycle signaling analysis indi-
cated a down-regulation of the major proteins that govern this
progress; cyclin D1, cyclin E, Cdk4, Cdk2, and Cdc25a. Without
the cyclin D1/Cdk4 and cyclin E/Cdk2 complex formation and its
Cdc25a-mediated activation, a reduced pRb phosphorylation
was expectedly observed, leading to a mild S entry, which was
conﬁrmed by a lower PCNA expression. In contrast, HPC of
malnourished mice showed p21 and p27 overexpression, which
are known proteins that promote cell cycle arrest in response to
nutrient limitations [41,42]. The normal levels of p53 suggest an
absence of DNA damage, because it is expected that a cell cycle
arrest is p53-mediated for the HPC in this situation [43–45].
Therefore, the cell cycle arrest appears to be an effective
Fig. 4. Effects of PM on cell cycle regulatory protein expression of HPC. Western blot analysis of cyclin D1, cyclin E, pRb, PCNA, Cdc25a, Cdk2, Cdk4, p21, p27, and p53 protein
expression (in arbitrary units). Results from three independents experiments expressed in relation to the intensity of b-actin. Mean  SD with signiﬁcant difference when
*P < 0.05 and zP < 0.001. Data set analyzed by the Student’s t test.
K. Nakajima et al. / Nutrition 30 (2014) 82–8988adaptation process reducing cell metabolism and minimizing
cell damage.
Cell cycle progression is triggered by a myriad of extracellular
signs that activate intracellular downstream effectors that
translate into cyclin D1 expression. Considering the structural
and biochemical BM microenvironment disarrangement
observed in PM, twomajor signaling pathways may contribute to
the down-regulation of cyclin D1 and consequently cell cycle
arrest: mitogen-activated protein kinase (MAPK) and mamma-
lian target of rapamycin (mTOR) [46,47]. Therefore, the bone
marrow ECM changes and stromal cells’ functional impairment
described in previous studies [8,9] could jeopardize cell in-
teractions, leading to an unsustained MAPK signaling. On the
other hand, the lack of insulin, IGF-1, glucose, and amino acids
shown in the present study also could inhibit mTOR signaling in
HPC. Hence, together with a restrained cell proliferation, mTOR
inactivation also could promote autophagy process, completing
the adaptation system mediated by lack of nutrients. Both hy-
potheses could shed some light on the physiopathology of
malnutrition and are now being investigated in our laboratory.
In other words, the structural changes in BM, previously
described as a consequence of PM, compromise cell interactions,
blunting the complex network that signalize cell cycle entry. By
affecting HPC proliferation, PM could be critical in some medical
conditions, especially in bone marrow transplantation, in whichBM microenvironment integrity could be critical to the cell
engraftment. Furthermore, by knowing how PM is compro-
mising hematopoiesis, we are now able to assess whether
nutritional recovery could restore blood system integrity.Conclusion
In conclusion, we observed that PM suppresses cell cycle
progression affecting the HPC proliferation. The G0-G1 arrest is
mediated by high levels of p21 and p27, and because there was
no p53 increasing, we assume that it is non-induced by DNA
damage. In parallel, a down-regulation of cyclin D1 expression
attests that BM microenvironment commitment observed in PM
is affecting cell interactions compromising cell proliferation and
leading to BM hypoplasia.Acknowledgments
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